The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
07:00 20-Jun-2016 HCM Savolitinib Global Phase II Trial Initiated RNS -1.40% Down
08:09 15-Jun-2016 HCM Additional Listing RNS -0.05% Down
07:00 31-May-2016 HCM Total Voting Rights RNS +9.65% Up
07:00 13-May-2016 HCM Enrollment completion of Phase III fruquintinib RNS -1.23% Down
07:00 29-Apr-2016 HCM Total Voting Rights RNS -4.49% Down
13:12 27-Apr-2016 HCM Results of Annual General Meeting RNS -4.99% Down
16:23 13-Apr-2016 HCM Exercise of Overallotment Option RNS +0.48% Up
07:00 12-Apr-2016 HCM Clinical trial of novel PI3K inhibitor HMPL-689 RNS +1.80% Up
07:00 31-Mar-2016 HCM Total Voting Rights RNS -2.27% Down
08:00 29-Mar-2016 HCM Director/PDMR Shareholding RNS -1.55% Down
10:34 23-Mar-2016 HCM Holding(s) in Company RNS -3.01% Down
14:00 22-Mar-2016 HCM Closing of U.S. Public Offering of ADSs RNS -7.81% Down
08:54 21-Mar-2016 HCM Director/PDMR Shareholding RNS -11.36% Down
07:00 21-Mar-2016 HCM Sulfatinib Phase III registration study RNS -11.36% Down
16:18 18-Mar-2016 HCM Final Prospectus RNS -16.03% Down
07:00 17-Mar-2016 HCM Pricing of U.S. Public Offering of ADSs RNS -18.96% Down
07:00 15-Mar-2016 HCM 2015 Annual Report and Notice of AGM RNS -11.62% Down
07:59 07-Mar-2016 HCM Fifth Filing of Form F-1 Registration Statement RNS +0.74% Up
18:12 04-Mar-2016 HCM Launch of Potential U.S. Public Offering of ADSs RNS +0.81% Up
17:54 04-Mar-2016 HCM Fifth Filing of Form F-1 Registration Statement RNS +0.81% Up

 Page 1 of 3

| 1 | 2 | 3 | Next

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address Ugland House, George Town, Grand Cayman, P.O. BOX 309, Cayman Islands
Company website -
Market cap(in millions)* £ 1,137.00
Listing/Admission to trading 19 May 2006
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIMI
MiFID Status MTF
Exchange market size 750
ISIN number KYG4672N1016

Start trading your favourite asset CFDs!
Carries risk of capital loss

HUTCHISON CHINA share news analysis (HCM)